<- Go Home
Omda AS
Omda AS provides software solutions for the healthcare and emergency response sector in Norway, Sweden, Denmark, Finland, and internationally. The company offers laboratory information management systems consisting of Omda ProSang, a blood, cell, and tissue management system; and medical medication solution comprising Omda Cytodose, an oncology medication management solution. It also provides connected healthcare solutions, including Omda Cardio, an ECG and diagnostic storage tool; Omda CIMA, a clinical imaging mobile application; Omda Media, a web-based medical imaging solution; Omda Medimaker, an image management and workflow solution; Omda Picsara, an image management solution; Omda Arcidis, an integrated teleradiology system; Omda Helsemail, an patient data transfer tool; Omda Plutus, an audit and workflow monitoring platform; Omda S7, a secure e-care communications platform; and Omda XDS, a patient data storage and management solution. In addition, the company offers Omda Fertsoft, a data solution for advanced assisted reproductive technology clinics; Omda iPana Hospital, a digital maternity solution; Omda iPana Maternity, a cloud-based platform for women maternity care; and Omda Partus, a data solution for the maternity sector, as well as health analytics products comprising Omda Compos, a medical data management solution; and Omda MedSciNet for collection, analysis, and management of medical data. Further, it provides Omda Optima that enables emergency organizations to test resource distribution and operational strategy through digital simulations; Omda CoordCom, an integrated emergency response platform; Omda AMIS, a digital platform for processing emergency calls and coordinating various aspects of the medical response; and Omda Paratus, an emergency response system. The company was formerly known as CSAM Health Group AS and changed its name to Omda AS in September 2023. Omda AS was founded in 1999 and is headquartered in Oslo, Norway.
Market Cap
NOK 920.8M
Volume
18.9K
Cash and Equivalents
NOK 53.7M
EBITDA
NOK 54.0M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
NOK 187.8M
Profit Margin
40.92%
52 Week High
NOK 57.40
52 Week Low
NOK 26.20
Dividend
1.05%
Price / Book Value
31.41
Price / Earnings
-36.05
Price / Tangible Book Value
-1.70
Enterprise Value
NOK 1.4B
Enterprise Value / EBITDA
25.07
Operating Income
NOK 18.9M
Return on Equity
59.45%
Return on Assets
1.58
Cash and Short Term Investments
NOK 53.7M
Debt
NOK 486.0M
Equity
NOK 29.3M
Revenue
NOK 459.0M
Unlevered FCF
NOK 65.5M
Sector
Health Care Technology
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium